Table 2 |
|||
|
Immune cell response following daily supplementation with 0, 2 or 8 mg astaxanthin after 0, 4 and 8 wk. |
|||
|
Treatment |
Wk 0 |
Wk 4 |
Wk 8 |
|
|
|||
|
Total T cells (%) |
|||
|
0 mg |
65.9 ± 2.1 |
64.4 ± 1.9b |
70.6 ± 1.5b |
|
2 mg |
69.5 ± 1.4 |
69.6 ± 1.5a |
75.7 ± 1.6a |
|
8 mg |
67.2 ± 2.2 |
69.6 ± 1.8a |
74.3 ± 1.8ab |
|
Total Th cells (%) |
|||
|
0 mg |
35.3 ± 1.5 |
36.3 ± 1.7 |
39.6 ± 1.4 |
|
2 mg |
35.3 ± 1.8 |
36.0 ± 1.9 |
39.7 ± 2.0 |
|
8 mg |
35.2 ± 1.5 |
34.3 ± 1.4 |
38.4 ± 1.2 |
|
Total Tc cells (%) |
|||
|
0 mg |
26.7 ± 1.4 |
26.1 ± 1.2 |
28.4 ± 1.4 |
|
2 mg |
28.2 ± 1.9 |
27.6 ± 1.9 |
28.7 ± 1.6 |
|
8 mg |
28.4 ± 1.6 |
28.3 ± 1.6 |
28.8 ± 2.1 |
|
Th:Tc ratio cells |
|||
|
0 mg |
1.35 ± 0.07 |
1.43 ± 0.09 |
1.48 ± 0.10 |
|
2 mg |
1.31 ± 0.15 |
1.35 ± 0.16 |
1.46 ± 0.15 |
|
8 mg |
1.31 ± 0.13 |
1.29 ± 0.13 |
1.37 ± 0.14 |
|
Total B cells (%) |
|||
|
0 mg |
11.4 ± 0.9 |
11.1 ± 0.5 |
10.7 ± 0.5b |
|
2 mg |
13.1 ± 1.1 |
12.7 ± 1.2 |
13.1 ± 0.5a |
|
8 mg |
13.3 ± 1.4 |
11.9 ± 0.7 |
11.1 ± 0.3ab |
|
Total NK cells (%) |
|||
|
0 mg |
13.7 ± 0.9 |
12.6 ± 1.2 |
10.6 ± 0.8 |
|
2 mg |
12.5 ± 1.0 |
13.1 ± 1.9 |
12.6 ± 1.5 |
|
8 mg |
13.4 ± 1.1 |
15.6 ± 1.4 |
13.1 ± 1.4 |
|
NK cytotoxic activity(% lysis) |
|||
|
0 mg |
51.5 ± 4.4 |
51.0 ± 2.5 |
57.8 ± 2.7b |
|
2 mg |
58.2 ± 3.8 |
54.4 ± 2.9 |
57.1 ± 2.6b |
|
8 mg |
56.1 ± 3.1 |
54.3 ± 1.9 |
67.9 ± 3.0a |
|
|
|||
|
a, b Different letters represent significant treatment differences (P < 0.05) as analyzed by ANOVA. Values are means ± SEM. |
|||
|
Park et al. Nutrition & Metabolism 2010 7:18 doi:10.1186/1743-7075-7-18 |
|||